Major surgery for metastatic bone disease is not a risk for 30-day mortality: a population-based study from Denmark




30-day mortality, Appendicular skeleton, Blood loss, Bone metastases, Extremities


Background and purpose: Surgery for bone metastases in the appendicular skeleton (aBM) is a trade-off between limb function and survival. A previous study from a highly specialized center found that extended surgery is not a risk for 30-day mortality and hypothesized that wide resection and reconstruction might reduce postoperative mortality. The study aimed to investigate whether parameters describing the surgical trauma (blood loss, duration of surgery, and degree of bone resection) pose a risk for 30-day mortality in patients treated with endoprostheses (EPR) or internal fixation (IF) in a population-based cohort.
Patients and methods: A population-based cohort having EPR/IF for aBM in the Capital Region of Denmark 2014–2019 was retrospectively assessed. Intraoperative variables and patient demographics were evaluated for association with 30-day mortality by logistic regression analysis. Kaplan–Meier estimate was used to evaluate survival with no loss to follow-up.
Results: 437 patients had aBM surgery with EPR/IF. No parameters describing the magnitude of the surgical trauma (blood loss/duration of surgery/degree of bone resection) were associated with mortality. Overall 30-day survival was 85% (95% confidence interval [CI] 81–88). Univariate analysis identified ASA group 3+4, Karnofsky score < 70, fast-growth primary cancer, and visceral and multiple bone metastases as risk factors for 30-day mortality. Male sex (OR 2.8, CI 1.3–6.3), Karnofsky score < 70 (OR 4.2, CI 2.1–8.6), and multiple bone metastases (OR 3.4, CI 1.2–9.9) were independent prognostic factors for 30-day-mortality in multivariate analysis.
Conclusion: The parameters describing the surgical trauma were not associated with 30-day mortality but, instead, general health status and extent of primary cancer influenced survival post-surgery.


Download data is not yet available.


Torre L A, Siegel R L, Ward E M, Jemal A. Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiol Biomarkers Prev 2016; 25: 16-27. doi: 10.1158/1055-9965.EPI-15-0578. DOI:

Janssen S J, Teunis T, Hornicek F J, van Dijk C N, Bramer J A M, Schwab J H. Outcome after fixation of metastatic proximal femoral fractures: a systematic review of 40 studies. J Surg Oncol 2016; 114: 507-19. doi:10.1002/jso.24345. DOI:

Harvey N, Ahlmann E R, Allison D C, Wang L, Menendez L R. Endoprostheses last longer than intramedullary devices in proximal femur metastases. Clin Orthop Relat Res 2012; 470: 684-91. doi:10.1007/s11999-011-2038-0. DOI:

Yong M, Jensen A Ö, Jacobsen J B, Nørgaard M, Fryzek J P, Sørensen H T. Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999–2007). Breast Cancer Res Treat 2011; 129: 495-503. doi: 10.1007/s10549-011-1475-5. DOI:

Sørensen M S, Gregersen K G, Grum-Schwensen T, Hovgaard D, Petersen M M. Patient and implant survival following joint replacement because of metastatic bone disease. Acta Orthop 2013; 84: 301-6. doi: 10.3109/17453674.2013.788437. DOI:

Schneiderbauer M M, von Knoch M, Schleck C D, Harmsen W S, Sim F H, Scully S P. Patient survival after hip arthroplasty for metastatic disease of the hip. J Bone Joint Surg Am 2004; 86: 1684-9. doi: 10.2106/00004623-200408000-00011. DOI:

Raschka T, Weiss S, Reiter A, Barg A, Schlickewei C, Frosch K H, et al. Outcomes and prognostic factors after surgery for bone metastases in the extremities and pelvis: a retrospective analysis of 140 patients. J Bone Oncol 2022; 34: 100427. doi: 10.1016/j.jbo.2022.100427. DOI:

Hara H, Sakai Y, Kawamoto T, Fukase N, Kawakami Y, Takemori T, et al. Surgical outcomes of metastatic bone tumors in the extremities (surgical outcomes of bone metastases). J Bone Oncol 2021; 27: 100352. doi: 10.1016/j.jbo.2021.100352. DOI:

Sørensen M S, Hovgaard T B, Hindsø K, Petersen M M. Prognostic value of biochemical variables for survival after surgery for metastatic bone disease of the extremities. J Surg Oncol 2017; 115: 442-8. doi: 10.1002/jso.24537. DOI:

Tsuda Y, Yasunaga H, Horiguchi H, Fushimi K, Kawano H, Tanaka S. Complications and postoperative mortality rate after surgery for pathological femur fracture related to bone metastasis: analysis of a nationwide database. Ann Surg Oncol 2016; 23: 801-10. doi: 10.1245/s10434-015-4881-9. DOI:

Sørensen M S, Hindsø K, Hovgaard T B, Petersen M M. Extent of surgery does not influence 30-day mortality in surgery for metastatic bone disease: an observational study of a historical cohort. Medicine (Baltimore) 2016; 95: e3354. doi: 10.1097/MD.0000000000003354. DOI:

Boddapati V, Held M B, Levitsky M, Charette R S, Neuwirth A L, Geller J A. Risks and complications after arthroplasty for pathological or impending pathological fracture of the hip. J Arthroplasty 2021; 36: 2049-54.e5. doi: 10.1016/j.arth.2021.02.004. DOI:

Bindels B J J, Thio Q C B S, Raskin K A, Ferrone M L, Lozano Calderón S A, Schwab J H. Thirty-day postoperative complications after surgery for metastatic long bone disease are associated with higher mortality at 1 year. Clin Orthop Relat Res 2020; 478: 306-18. doi: 10.1097/CORR.0000000000001036. DOI:

Barrett W P, Turner S E, Leopold J P. Prospective randomized study of direct anterior vs postero-lateral approach for total hip arthroplasty. J Arthroplasty 2013; 28: 1634-8. doi: 10.1016/j.arth.2013.01.034. DOI:

Brunello M, Di Martino A, Ruta F, Ferri R, Rossomando V, Agostino C D, et al. Which patient benefit most from minimally invasive direct anterior approach total hip arthroplasty in terms of perioperative blood loss? A retrospective comparative study from a cohort of patients with primary degenerative hips. Musculoskelet Surg 2023; online ahead of print. doi: 10.1007/s12306-023-00792-z. DOI:

Schoenfeld A J, Carey P A, Cleveland A W, Bader J O, Bono C M. Patient factors, comorbidities, and surgical characteristics that increase mortality and complication risk after spinal arthrodesis: a prognostic study based on 5,887 patients. Spine J 2013; 13: 1171-9. doi: 10.1016/j.spinee.2013.02.071. DOI:

Pugely A J, Martin C T, Gao Y, Ilgenfritz R, Weinstein S L. The incidence and risk factors for short-term morbidity and mortality in pediatric deformity spinal surgery: an analysis of the NSQIP pediatric database. Spine (Phila Pa 1976) 2014; 39: 1225-34. doi: 10.1097/BRS.0000000000000365. DOI:

Ladegaard T H, Sørensen C L, Nielsen R, Troelsen A, Al-Mousawi D A A, Bielefeldt R, et al. Surgical treatment of metastatic bone disease in the appendicular skeleton: a population-based study. Cancers (Basel) 2022; 14: 1258. doi: 10.3390/cancers14051258. DOI:

Denmark Statistics Population—Capital Region of Denmark Available from: (accessed August 7, 2023).

ASA Physical Status Classification System. Available from:

Katagiri H, Okada R, Takagi T, Takahashi M, Murata H, Harada H, et al. New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med 2014; 3: 1359-67. doi: 10.1002/cam4.292. DOI:

Hansen B H, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, et al. The Scandinavian Sarcoma Group skeletal metastasis register: survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand 2004; 75: 11-15. doi: 10.1080/00016470410001708270. DOI:

Bauer H C, Wedin R. Survival after surgery for spinal and extremity metastases: prognostication in 241 patients. Acta Orthop Scand 1995; 66: 143-6. doi: 10.3109/17453679508995508. DOI:

Forsberg J A, Eberhardt J, Boland P J, Wedin R, Healey J H. Estimating survival in patients with operable skeletal metastases: an application of a Bayesian Belief Network. PLoS One 2011; 6: e19956. doi: 10.1371/journal.pone.0019956. DOI:

Shallop B, Starks A, Greenbaum S, Geller D S, Lee A, Ready J, et al. Thromboembolism after intramedullary nailing for metastatic bone lesions. J Bone Joint Surg Am 2015; 97: 1503-11. doi: 10.2106/JBJS.N.01067. DOI:

Sørensen M S, Gerds T A, Hindsø K, Petersen M M. Prediction of survival after surgery due to skeletal metastases in the extremities. Bone Joint J 2016; 98-B: 271-7. doi: 10.1302/0301-620X.98B2.36107. DOI:

Dodd A C, Bulka C, Jahangir A, Mir H R, Obremskey W T, Sethi M K. Predictors of 30-day mortality following hip/pelvis fractures. Orthop Traumatol Surg Res 2016; 102: 707-10. doi: 10.1016/j.otsr.2016.05.016. DOI:

Harman H, Walton T J, Chan G, Stott P, Ricketts D M, Rogers B A. Predicting 30-day mortality after hip fracture: the G4A calibrated prognostic tool. HIP Int 2022; 32: 820-5. doi: 10.1177/1120700021998959. DOI:

Sørensen M S, Horstmann P F, Hindsø K, Petersen M M. Use of endoprostheses for proximal femur metastases results in a rapid rehabilitation and low risk of implant failure: a prospective population-based study. J Bone Oncol 2019; 19: 100264. doi: 10.1016/j.jbo.2019.100264. DOI:



How to Cite

Ladegaard, T. H., Sørensen, M. S., & Petersen, M. M. (2023). Major surgery for metastatic bone disease is not a risk for 30-day mortality: a population-based study from Denmark. Acta Orthopaedica, 94, 447–452.





Most read articles by the same author(s)